The Department of Health – Abu Dhabi (DoH) has announced launching a Real-World Evidence Study to offer critical real-world data on the safety and effectiveness of AstraZeneca’s long-acting antibody combination, Evusheld. Evusheld was launched last March in UAE to protect immunocompromised patients against COVID-19. It......